Development and Validation of Bio Analytical Method for Estimation of Bortezomib in k3 EDTA Human Plasma Using HPLC-ESI-MS/MS and Its Application to a Bioequivalence & CME Studies
Ravi Pulla, K Prakash, U Abhini, B Maheswari, V Divya, M Shushmitha & V Ravali · British Journal of Pharmaceutical Research · 2016
Purpose: To develop a highly selective, reproducible & precise rugged bio analytical method for estimation of Bortezomib (BTZ), “A Protease Inhibitor” in human plasma by validating the developed method in accordance to US-FDA guidelines. Methodology Envisaged: BTZ D3 was used as...
Open access
Research Article
10.9734/bjpr/2016/30565